SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Compare Gene Therapy CDMOs in USA
Compare AAV CDMOs in USA
Compare Lentiviral CDMOs in USA
Compare Adenoviral CDMOs in USA
Compare ADC CDMOs in USA
Compare Cell Therapy CDMOs in USA
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
79.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (3)
○ MHRA GMP
Quick Facts: SK pharmteco
- Signal Score
- 79.5/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100 — Clean EMA record: 3 active GMP certificates (no deductions)
- Headquarters
- Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
- Website
- https://sk-pharmteco.com
- Modalities
- Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 3 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 3 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates3 on record
Clean EMA record: 3 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesViral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
63.0
Broad modality coverage (10 modalities)
Sites: Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
StatusAvailable
Broad modality coverage (10 modalities)
Sites: Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Press Signals1 articles (not scored)
Broad modality coverage (10 modalities)
SK pharmteco EMA GMP Compliance 3 certificates
2025-11
2025-11
2022-04
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 2026_HPF_FR_076_IV | YposKesi | France | 2025-11-28 | COMPLIANT |
| 2026_HPF_FR_075_IV | YposKesi | France | 2025-11-28 | COMPLIANT |
| 2022_HPF_FR_143_1_P_2025 | YposKesi | France | 2022-04-08 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity Beta
From public job postings on SK pharmteco's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No open roles were listed on Nov 20, 2026.
Coverage: counted from SK pharmteco's own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
skpharmteco.com
· Checked Nov 20, 2026 · Tracking since Oct 30, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
Exclusive: SK pharmteco unveils $200M+ investment to expand CDMO capabilities - Endpoints News
Exclusive: SK pharmteco unveils $200M+ investment to expand CDMO capabilities Endpoints News
Frequently Asked Questions About SK pharmteco
Does SK pharmteco hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA GMP certificates for SK pharmteco.
What is SK pharmteco's CDMO Signal Score?
SK pharmteco has a Signal Score of 80/100, based on quality, operations, financial stability, and capacity data.
Evaluating SK pharmteco for a manufacturing program?
Use the free AI matchmaker to compare SK pharmteco against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
NecstGen
Leiden, NL
Signal Score: 78.1
AAV, Lentiviral, Cell Therapy
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Compare SK pharmteco with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.